Table 2.
Patient no. | Sex | Age at first scan (years) | Age at second scan (years) | Interval between scans (years) | Rapid cycling | Medications at scan 1 | Medications at scan 2 | Comorbid diagnoses |
---|---|---|---|---|---|---|---|---|
1 | Female | 11.7 | 14.3 | 2.6 | Scans 1 & 2 | None | None | Social phobia |
2 | Female | 15.8 | 18.6 | 2.8 | Scan 2 | None | Birth control pills | None |
3 | Female | 16.6 | 18.8 | 2.2 | Scans 1 & 2 | None | Birth control pills | None |
4 | Female | 17.2 | 20.2 | 3.0 | Scan 2 | Carbamazepine, levothyroxine | None | Oppositional defiant disorder, post-traumatic stress disorder, hypothyroidism |
5 | Female | 21.5 | 23.6 | 2.1 | Scan 1 | None | None | History of alcohol dependence, hallucinogen and marijuana abuse |
6 | Male | 10.7 | 12.7 | 2.0 | Scans 1 & 2 | Lithium | None | Oppositional defiant disorder |
7 | Male | 11.7 | 14.0 | 2.2 | Scan 2 | VPA, olanzapine, methylphenidate, clonidine | Olanzapine, methylphenidate | ADHD, developmental coordination disorder |
8 | Male | 12.0 | 14.6 | 2.5 | Scan 1 | VPA, nortriptyline | VPA, nortriptyline, methylphenidate | Learning disorder NOS |
9 | Male | 12.2 | 15.6 | 3.3 | None | Lithium, risperidone, sertraline | Lithium, VPA, risperidone, sertraline, atomoxetine | Learning disorder NOS |
10 | Male | 20.8 | 23.0 | 2.2 | Scans 1 & 2 | None | None | None |
VPA = valproic acid; ADHD = Attention-deficit hyperactivity disorder; NOS = not otherwise specified.